Natco Pharma Ltd.
BSE: 524816 | Sector: Health care |
NSE: NATCOPHARM | ISIN Code: INE987B01026 |
BSE 09:34 | 04 Jul | 650.00 |
-0.70 (-0.11%) |
OPEN
662.00 |
HIGH
662.00 |
LOW
648.60 |
NSE 09:24 | 04 Jul | 652.00 |
1.60 (0.25%) |
OPEN
655.00 |
HIGH
657.80 |
LOW
649.50 |
OPEN | 662.00 |
PREVIOUS CLOSE | 650.70 |
VOLUME | 991 |
52-Week high | 1188.05 |
52-Week low | 607.95 |
P/E | 85.30 |
Mkt Cap.(Rs cr) | 11,866 |
Buy Price | 649.00 |
Buy Qty | 24.00 |
Sell Price | 650.00 |
Sell Qty | 17.00 |
- Financial Overview
- Balance Sheet
- Profit & Loss
- Cash Flow
- Ratios
- Quarterly
- Half Yearly
- Nine Monthly
- Yearly
Filter:
Natco Pharma Ltd. (NATCOPHARM) - Yearly Result
Particulars (![]() |
Mar '22 | Mar '21 | Mar '20 | Mar '19 | Mar '18 |
Net Sales/Income From Operations | 1767.80 | 1653.50 | 1790.20 | 1986.30 | 2091.30 |
Other Income | 94.60 | 101.10 | 123.80 | 129.80 | 39.40 |
Total Income | 1862.40 | 1754.60 | 1914.00 | 2116.10 | 2130.70 |
Total Expenditure | 1554.80 | 1235.90 | 1212.20 | 1169.80 | 1162.90 |
Operating Profit | 307.60 | 518.70 | 701.80 | 946.30 | 967.80 |
Interest | 13.30 | 11.30 | 20.60 | 18.80 | 14.70 |
Gross Profit | 294.30 | 507.40 | 681.20 | 927.50 | 953.10 |
Depreciation | 138.40 | 115.20 | 98.10 | 80.10 | 65.50 |
PBT | 155.90 | 392.20 | 583.10 | 847.40 | 887.60 |
Tax | 32.50 | 93.30 | 129.10 | 186.30 | 217.30 |
Net Profit/(Loss) | 139.10 | 309.50 | 474.50 | 667.10 | 698.20 |
Minority Interest After NP | - | - | - | - | - |
Net Profit after Minority Interest | - | - | - | - | - |
Exceptional Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Profit After Exceptional Items | 139.10 | 309.50 | 474.50 | 667.10 | 698.20 |
Equity Share Capital | 36.50 | 36.50 | 36.40 | 36.50 | 36.90 |
Reserves Excluding Revaluation Reserves | 4155.40 | 4054.60 | 3833.10 | 3526.70 | 3088.50 |
EPS | |||||
Basic EPS | 7.63 | 16.99 | 26.08 | 36.22 | 39.38 |
Public Share Holding | |||||
No Of Shares (Crores) | 0 | 0 | 0 | 0 | 0 |
Share Holding (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Promoters and Promoter Group Shareholding | |||||
a) Pledged/Encumbered | |||||
- Number of Shares (Crores) | 0 | 0 | 0 | 0 | 0 |
- Per. of Shares (as a % of the total sh. of prom. and promoter group) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
- Per. of Shares (as a % of the total Share Cap. of the company) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
b) Non-encumbered | |||||
- Number of Shares (Crores) | 0 | 0 | 0 | 0 | 0 |
- Per. of shares (as a % of the total sh. of prom. and promoter group) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
- Per. of shares (as a % of the total Share Cap. of the company) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Note : | PBT include deferred tax and fringe benefit tax Net profit figures include extra-ordinary items income/expenditure. |
Quick Links for Natco Pharma:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices